Organon & Co | OGN - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Bristol-Myers Squibb USD 255M 44M 2026-09
Celltrion KRW 19.31B 6.4B 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 14.24B 2.95B 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Glaxosmithkline GBP 2.13B 166M 2026-09
Kangmei Pharma CNY -35.26M 24.32M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD 7.33B 6.49B 2026-09
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 1.84B 2.39B 2026-09
Organigram Holdings CAD 5.33M 15.12M 2026-06
Organon & Co USD 377M 54M 2026-09
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR 7.65M 9.06M 2026-09
Qiagen NV USD 141.4M 24.77M 2026-06
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -539M 168.05M 2026-03